Slider

The NSW Government has published the Medicines, Poisons and Therapeutic Goods Regulation 2026, setting a new compliance baseline for the...

Interest in GLP-1 receptor agonists has largely focused on weight loss, metabolic disease and cardiometabolic risk. New findings suggest their...

Aerolase is marking its 30-year anniversary in 2026, reflecting on three decades of laser technology development and its ongoing role...

Celebrating its 10th anniversary, Cosmedicon will take place from 26–28 February 2027 at the Hyatt Regency Sydney. Hosted by Aesthetic Medical...

The Therapeutic Goods Administration (TGA) has released new guidance on advertising restrictions for prescription medicines, with examples that place weight-loss...

Beauty has spent years chasing youth, but some of the category’s strongest spending is coming from consumers the industry has...

Concern about muscle loss has become one of the main questions around GLP-1 and related weight-loss medicines. As drugs such...

Tetra PRO by DEKA introduces a new level of control to CO₂ laser treatments, giving clinicians the ability to adjust...

The wellness economy has long moved faster than regulation. But the latest scrutiny around peptides suggests that the gap between...

Dr Giulia D’Anna In aesthetic medicine, treating the upper face with botulinum toxin is often seen as a foundational procedure....